Toward International Harmonization of Breast Implant Registries: International Collaboration of Breast Registry Activities Global Common Data Set.

Breast Implants / adverse effects Breast Neoplasms / surgery Congresses as Topic Consensus Female Global Health Humans Incidence Lymphoma, Large-Cell, Anaplastic / epidemiology Mammaplasty / adverse effects Registries

Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 3 8 2020
pubmed: 3 8 2020
medline: 2 9 2020
Statut: ppublish

Résumé

The Poly Implant Prothèse incident and breast implant-associated anaplastic large cell lymphoma have pointed to the need for uniform registries for breast implants as key features to monitoring the outcomes of breast implant surgeries internationally. The purpose of this study was to identify and harmonize common data elements collected by breast implant registries across the International Collaboration of Breast Registry Activities (ICOBRA) global consortium. The authors convened an international group of surgeons, consumers, nurses, registry experts, and regulators to review the data points. A modified Delphi approach was applied, to rate the importance of each point on a six-point Likert scale. Data points from six national breast implant registries were divided into categories: clinical, implant-related, patient-reported findings; operation details and implanting technique details; patient characteristics; unique device identifiers; unique patient identifiers; and clinical demographics. A total of 52 data points collected by over 33 percent of national registries were identified. After five rounds, 34 data points formed the final set with agreed definitions. The group recognized the critical importance of additional elements that are currently not uniformly collected (e.g., patient-reported outcomes and long-term data) and set out the process for the dynamic global set updates driven by evidence gaps. The authors defined internationally agreed on common data elements and definitions used in breast implant registries. This collaboration will allow data sets to be combined, enabling an effective global early warning system of implant-related problems and further work on data sets.

Sections du résumé

BACKGROUND
The Poly Implant Prothèse incident and breast implant-associated anaplastic large cell lymphoma have pointed to the need for uniform registries for breast implants as key features to monitoring the outcomes of breast implant surgeries internationally. The purpose of this study was to identify and harmonize common data elements collected by breast implant registries across the International Collaboration of Breast Registry Activities (ICOBRA) global consortium.
METHODS
The authors convened an international group of surgeons, consumers, nurses, registry experts, and regulators to review the data points. A modified Delphi approach was applied, to rate the importance of each point on a six-point Likert scale.
RESULTS
Data points from six national breast implant registries were divided into categories: clinical, implant-related, patient-reported findings; operation details and implanting technique details; patient characteristics; unique device identifiers; unique patient identifiers; and clinical demographics. A total of 52 data points collected by over 33 percent of national registries were identified. After five rounds, 34 data points formed the final set with agreed definitions. The group recognized the critical importance of additional elements that are currently not uniformly collected (e.g., patient-reported outcomes and long-term data) and set out the process for the dynamic global set updates driven by evidence gaps.
CONCLUSIONS
The authors defined internationally agreed on common data elements and definitions used in breast implant registries. This collaboration will allow data sets to be combined, enabling an effective global early warning system of implant-related problems and further work on data sets.

Identifiants

DOI: 10.1097/PRS.0000000000006969 PMID: 32740572
pubmed: 32740572
doi: 10.1097/PRS.0000000000006969
pii: 00006534-202008000-00009
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-267

Références

Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast reconstruction: Increasing implant rates. Plast Reconstr Surg. 2013;131:15–23.
de Boer M, van Leeuwen FE, Hauptmann M, et al. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol. 2018;4:335–341.
Angell M. Shattuck lecture: Evaluating the health risks of breast implants. The interplay of medical science, the law, and public opinion. N Engl J Med. 1996;334:1513–1518.
Balk EM, Earley A, Avendano EA, Raman G. Long-term health outcomes in women with silicone gel breast implants: A systematic review. Ann Intern Med. 2016;164:164–175.
Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000;342:781–790.
U.S. Food & Drug Administration. Update on the safety of silicone gel-filled breast implants center for devices and radiological health. Available at: https://www.fda.gov/downloads/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/breastimplants/ucm260090.pdf. Accessed March 31, 2018.
Stevens WG, Harrington J, Alizadeh K, Broadway D, Zeidler K, Godinez TB. Eight-year follow-up data from the U.S. clinical trial for Sientra’s FDA-approved round and shaped implants with high-strength cohesive silicone gel. Aesthet Surg J. 2015;35(Suppl 1):S3–10.
de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300:2030–2035.
Jeeves AE, Cooter RD. Transforming Australia’s breast implant registry. Med J Aust. 2012;196:232–234.
Hopper I, Ahern S, McNeil JJ, et al. Improving the safety of breast implants: Implant-associated lymphoma. Med J Aust. 2017;207:185–186.
Wilkinson J, Crosbie A. A UK medical devices regulator’s perspective on registries. Biomed Tech (Berl.) 2016;61:233–237.
Krucoff MW, Normand S, Edwards F, et al. Recommendations for a national medical device evaluation system. Available at: https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhreports/ucm459368.pdf. Accessed August, 29, 2018.
Inspectie voor de Gezondheidszorg. Medische technologie Siliconen borstimplantaten. Available at: http://www.igz.nl/onderwerpen/medische-technologie/actuele-onderwerpen/borstimplantaten. Accessed March 31, 2018.
Hopper I, Ahern S, Best RL, McNeil J, Cooter RD. Australian Breast Device Registry: Breast device safety transformed. ANZ J Surg. 2017;87:9–10.
Rakhorst HA, Mureau MAM, Cooter RD, et al. The new opt-out Dutch National Breast Implant Registry: Lessons learnt from the road to implementation. J Plast Reconstr Aesthet Surg. 2017;70:1354–1360.
Cooter RD, Barker S, Carroll SM, et al. International importance of robust breast device registries. Plast Reconstr Surg. 2015;135:330–336.
The Breast Implant Register. The Bröstimplantatregistret of Sweden (BRIMP). Available at: https://registercentrum.blob.core.windows.net/brimp/r/BRIMP_Annual_Report_2017-SJxwMLyP7S.pdf. Accessed March 31, 2018.
Wurzer P, Rappl T, Friedl H, et al. The Austrian breast implant register: Recent trends in implant-based breast surgery. Aesthetic Plast Surg. 2014;38:1109–1115.
Breast and Cosmetic Implant Registry (BCIR). Available at: http://content.digital.nhs.uk/bcir. Accessed March 31, 2018.
Dalkey NC. The Delphi Method: An Experimental Study of Group Opinion. Rand Corp Public RM-58888-PR. 1969.Santa Monica, Calif: Rand Corp;
Qualtrics. Intext Qualtrics. 2005.Provo, Utah: Queltrics Software;
Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User’s Manual. 2001.Santa Monica, Calif: Rand Corp;
Kuskowska-Wolk A, Bergström R, Boström G. Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord. 1992;16:1–9.
Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: Descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol. 2018;37:483–493.
Jara LJ, García-Collinot G, Medina G, et al. Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld’s syndrome). Immunol Res. 2017;65:8–16.
Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Jara LJ, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): Clinical and immunological spectrum. Expert Rev Clin Immunol. 2013;9:361–373.
Rohrich RJ, Kaplan J, Dayan E. Silicone implant illness: Science vs myth? Plast Reconstr Surg. 2019;144:98–109.
Becherer BE, de Boer M, Spronk PER, et al. The Dutch Breast Implant Registry: Registration of breast implant-associated anaplastic large cell lymphoma. A proof of concept. Plast Reconstr Surg. 2019;143:1298–1306.
Ahern S, Hopper I, Evans SM. Clinical quality registries for clinician-level reporting: Strengths and limitations. Med J Aust. 2017;206:427–429.
Govaert JA, van Bommel AC, van Dijk WA, van Leersum NJ, Tollenaar RA, Wouters MW. Reducing healthcare costs facilitated by surgical auditing: A systematic review. World J Surg. 2015;39:1672–1680.
Henderson JR, Kandola S, Hignett SP, et al. Infection prophylaxis for breast implant surgery: Could we do better? Eplasty 2017;17:e19.
Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med. 2008;5:e67.
Becherer BE, Spronk PER, Mureau MAM, et al. High risk device registries: Global value, costs, and sustainable funding. J Plast Reconstr Aesthet Surg. 2018;71:1362–1380.
European Commission. General data protection regulation. Available at: https://www.eugdpr.org/ Accessed March 31, 2018.
Sedrakyan A, Paxton EW, Marinac-Dabic D. Stages and tools for multinational collaboration: The perspective from the coordinating center of the International Consortium of Orthopaedic Registries (ICOR). J Bone Joint Surg Am. 2011;93(Suppl 3):76–80.
Ng S, Pusic A, Parker E, et al. Patient-reported outcome measures for breast implant surgery: A pilot study. Aesthet Surg J. 2019;39:NP314–NP321.
Warren Peled A, Foster RD, Stover AC, et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol. 2012;19:3402–3409.

Auteurs

Pauline E R Spronk (PER)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Husna Begum (H)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Swarna Vishwanath (S)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Andy Crosbie (A)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Arul Earnest (A)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Elisabeth Elder (E)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

David B Lumenta (DB)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Danica Marinac-Dabic (D)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Colin C M Moore (CCM)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Marc A M Mureau (MAM)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Graeme Perks (G)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Andrea L Pusic (AL)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Birgit Stark (B)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Uwe von Fritschen (U)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Howard Klein (H)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Rodney D Cooter (RD)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Hinne A Rakhorst (HA)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Ingrid Hopper (I)

From the Department of Surgery, Leiden University Medical Center; the Department of Research, Dutch Institute for Clinical Auditing; the Department of Epidemiology and Preventive Medicine, Monash University; the Medicines and Healthcare Products Regulatory Agency; Westmead Breast Cancer Institute, University of Sydney; Breast Surgeons of Australia and New Zealand; the Division of Plastic, Aesthetic, and Reconstructive Surgery, Department of Surgery, Medical University of Graz; the Division of Epidemiology, Center for Devices and Radiological Health, U.S. Food and Drug Administration; the Australian Centre for Cosmetic Surgery; the Australasian College of Cosmetic Surgery; the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam; the Department of Plastic and Reconstructive Surgery, Nottingham University Hospitals NHS Trust; the Department of Plastic and Reconstructive Surgery, Brigham Health; the Department for Molecular Medicine and Surgery, Karolinska Institute; the Department of Plastic and Reconstructive Surgery, Hand Surgery, Helios-Clinic Emil-von-Behring; the Department of Plastic Surgery, St. George's Hospital; the Australian Society of Plastic Surgeons; and the Department of Plastic, Reconstructive, and Hand Surgery, Medisch Spectrum Twente.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Équipement et fournitures › Prothèses et implants › Implants mammaires › Toward International Harmonization of Breast...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Toward International Harmonization of Breast...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Congrès comme sujet › Toward International Harmonization of Breast...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Toward International Harmonization of Breast...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Toward International Harmonization of Breast...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Toward International Harmonization of Breast...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Incidence › Toward International Harmonization of Breast...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome T › Lymphome à grandes cellules anaplasiques › Toward International Harmonization of Breast...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie reconstructive › Mammoplastie › Toward International Harmonization of Breast...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enregistrements › Toward International Harmonization of Breast...